CXCR2 and posterior cortical atrophy: demonstrated that CXCR2 expression could alter the phenotype of PCa cells, and the inhibition of CXCR2 expression in neuroendocrine PCa cells had the significance to re-sensitized enzalutamide-resistant PCa to enzalutamide (19).